Cullen Investment Group, Ltd. Dexcom Inc Transaction History
Cullen Investment Group, Ltd.
- $678 Billion
- Q4 2024
A detailed history of Cullen Investment Group, Ltd. transactions in Dexcom Inc stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 11,502 shares of DXCM stock, worth $970,538. This represents 0.13% of its overall portfolio holdings.
Number of Shares
11,502
Previous 10,888
5.64%
Holding current value
$970,538
Previous $730 Million
22.55%
% of portfolio
0.13%
Previous 0.11%
Shares
4 transactions
Others Institutions Holding DXCM
# of Institutions
1,019Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$4 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.91 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.51 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.41 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.27 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $32.6B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...